A Preview Of Reshape Lifesciences's Earnings
Portfolio Pulse from Benzinga Insights
Reshape Lifesciences (NASDAQ:RSLS) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-1.20. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price the following day. The stock is currently trading at $0.2376, down 97.56% over the last 52-week period.
November 07, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Reshape Lifesciences is expected to report an EPS of $-1.20. The company's history of beating EPS estimates but experiencing share price drops could continue, impacting the stock negatively.
Reshape Lifesciences has a history of beating EPS estimates but experiencing a drop in share price the following day. If this trend continues, it could lead to a negative impact on the stock. Additionally, the stock has been on a downward trend, decreasing by 97.56% over the last 52-week period, which could further negatively impact investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100